• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病视网膜病变微量白蛋白尿与其他可改变的危险因素的关系。

Relationship between diabetic retinopathy microalbuminuria and other modifiable risk factors.

机构信息

Hamdard Institute of Medical Sciences and Research, New Delhi, India.

Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, India.

出版信息

Prim Care Diabetes. 2021 Jun;15(3):567-570. doi: 10.1016/j.pcd.2021.01.012. Epub 2021 Feb 4.

DOI:10.1016/j.pcd.2021.01.012
PMID:33551334
Abstract

BACKGROUND

Diabetic Retinopathy (DR) is an important microvascular complication of diabetes that can lead to irreversible blindness. Microalbuminuria is strongly associated with diabetic retinopathy and can be used as a reliable marker of diabetic retinopathy.

AIM

To assess the association between DR, microalbuminuria, and other modifiable risk factors in patients with type 2 diabetes.

METHODOLOGY

3090 patients with T2DM visiting North Delhi Diabetes Centre, New Delhi between July 2016 to October 2019 were evaluated for the clinical and biochemical parameters that included urinary albumin, HbA1C, lipid profiles, serum creatinine estimation and underwent biothesiometry.

RESULTS

3090 patients (1350 females and 1740 males), with mean age of 52.7 ± 9.2 years and diabetes duration ranging from 1 to 19 years (mean 9.4 ± 6), duration of less than 5 years, 6-10 years and more than 10 years in 52%, 26% and in 22%, respectively. Duration of diabetes was strong predictor of retinopathy (p = 0.001). The HbA1c and BMI in patients with DR was significantly higher than in those without DR. 18.2% patients were diagnosed to have retinopathy. Peripheral neuropathy was observed in 24.2% and was positively associated with DR (p = 0.002). 33.9% and 4.5% patients had microalbuminuria macroalbuminuria, respectively and 9.7% patients had creatinine >1.3 mg/dL. There was significant positive relationship between different grades of retinopathy and albuminuria.

CONCLUSIONS

Our study is a large real-world study that demonstrates that HbA1c, BMI, duration of diabetes, microalbuminuria and peripheral neuropathy are relatively, yet cohesively contributing factors towards varying grade of retinopathy.

摘要

背景

糖尿病视网膜病变(DR)是糖尿病的一种重要的微血管并发症,可导致不可逆性失明。微量白蛋白尿与糖尿病视网膜病变密切相关,可作为糖尿病视网膜病变的可靠标志物。

目的

评估 2 型糖尿病患者中 DR、微量白蛋白尿和其他可改变的危险因素之间的关联。

方法

2016 年 7 月至 2019 年 10 月,对 3090 名在新德里北德里糖尿病中心就诊的 T2DM 患者进行了临床和生化参数评估,这些参数包括尿白蛋白、HbA1C、血脂谱、血清肌酐估计值,并进行了生物感觉测定。

结果

3090 名患者(1350 名女性和 1740 名男性),平均年龄为 52.7 ± 9.2 岁,糖尿病病程 1-19 年(平均 9.4 ± 6 年),病程<5 年、6-10 年和>10 年的患者分别占 52%、26%和 22%。糖尿病病程是视网膜病变的强预测因素(p = 0.001)。DR 患者的 HbA1c 和 BMI 显著高于无 DR 患者。18.2%的患者被诊断为视网膜病变。周围神经病变发生率为 24.2%,与 DR 呈正相关(p = 0.002)。33.9%和 4.5%的患者分别有微量白蛋白尿和大量白蛋白尿,9.7%的患者肌酐>1.3mg/dL。不同程度的视网膜病变与白蛋白尿之间存在显著的正相关关系。

结论

我们的研究是一项大型真实世界研究,表明 HbA1c、BMI、糖尿病病程、微量白蛋白尿和周围神经病变是导致不同程度视网膜病变的相对但协同的因素。

相似文献

1
Relationship between diabetic retinopathy microalbuminuria and other modifiable risk factors.糖尿病视网膜病变微量白蛋白尿与其他可改变的危险因素的关系。
Prim Care Diabetes. 2021 Jun;15(3):567-570. doi: 10.1016/j.pcd.2021.01.012. Epub 2021 Feb 4.
2
Diabetic retinopathy and microalbuminuria in lean type 2 diabetes mellitus.瘦型2型糖尿病中的糖尿病视网膜病变和微量白蛋白尿
J Assoc Physicians India. 2001 Apr;49:439-41.
3
Correlation of Albuminuria and Diabetic Retinopathy in Type-II Diabetes Mellitus Patients.2型糖尿病患者蛋白尿与糖尿病视网膜病变的相关性
Cureus. 2022 Feb 5;14(2):e21927. doi: 10.7759/cureus.21927. eCollection 2022 Feb.
4
Retinopathy and microalbuminuria in type II diabetic patients.II型糖尿病患者的视网膜病变和微量白蛋白尿
BMC Ophthalmol. 2004 Jul 1;4:9. doi: 10.1186/1471-2415-4-9.
5
Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study.白蛋白尿型慢性肾脏病与 2 型糖尿病患者糖尿病视网膜病变的真实世界关联:来自 No blind 研究的结果。
Nutr Metab Cardiovasc Dis. 2019 Sep;29(9):923-930. doi: 10.1016/j.numecd.2019.05.065. Epub 2019 Jun 7.
6
Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus.泰国糖尿病登记项目:1型糖尿病患者糖尿病视网膜病变的患病率及相关因素
J Med Assoc Thai. 2006 Aug;89 Suppl 1:S17-26.
7
Early Diabetic Nephropathy and Retinopathy in Patients with Type 1 Diabetes Mellitus Attending Sudan Childhood Diabetes Centre.1 型糖尿病患儿在苏丹儿童糖尿病中心就诊时的早期糖尿病肾病和视网膜病变。
J Diabetes Res. 2020 Nov 24;2020:7181383. doi: 10.1155/2020/7181383. eCollection 2020.
8
Effect of microalbuminuria on macular thickness in patients with type-2 diabetes mellitus.微量白蛋白尿对2型糖尿病患者黄斑厚度的影响。
Eur J Ophthalmol. 2020 Jan;30(1):19-25. doi: 10.1177/1120672118811256. Epub 2018 Nov 8.
9
High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown.上海市中心确诊为2型糖尿病的社区患者中蛋白尿的高患病率。
Diabetes Res Clin Pract. 2007 Feb;75(2):184-92. doi: 10.1016/j.diabres.2006.06.024. Epub 2006 Aug 8.
10
Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications Study.日本 2 型糖尿病患者的糖尿病视网膜病变和微量白蛋白尿可预测大量白蛋白尿和肾功能下降:日本糖尿病并发症研究。
Diabetes Care. 2013 Sep;36(9):2803-9. doi: 10.2337/dc12-2327. Epub 2013 Apr 25.

引用本文的文献

1
Discordance of diabetic retinopathy severity in a cohort of diabetic nephropathy patients: a cross-sectional case-control study in a new Mexican population of type 2 diabetes.一组糖尿病肾病患者中糖尿病视网膜病变严重程度的不一致性:一项针对新墨西哥州2型糖尿病患者群体的横断面病例对照研究
Front Endocrinol (Lausanne). 2025 Aug 1;16:1638415. doi: 10.3389/fendo.2025.1638415. eCollection 2025.
2
Association between FT4/FT3 ratio and microalbuminuria in euthyroid patients with type 2 diabetes mellitus.2型糖尿病甲状腺功能正常患者中游离甲状腺素/游离三碘甲腺原氨酸比值与微量白蛋白尿的关系
Sci Rep. 2025 Mar 1;15(1):7324. doi: 10.1038/s41598-025-92046-0.
3
Insights into the systemic risk factors associated with diabetic retinopathy in the Indian population: A comprehensive systematic review and meta-analysis.
印度人群中与糖尿病视网膜病变相关的系统性风险因素的见解:一项全面的系统综述和荟萃分析。
Indian J Ophthalmol. 2025 Jan 1;73(Suppl 1):S24-S30. doi: 10.4103/IJO.IJO_818_24. Epub 2024 Dec 24.
4
Incidence of Diabetic Retinopathy in Individuals with Type 2 Diabetes: A Study Using Real-World Data.2型糖尿病患者糖尿病视网膜病变的发病率:一项基于真实世界数据的研究。
J Clin Med. 2024 Nov 23;13(23):7083. doi: 10.3390/jcm13237083.
5
Parallelism and non-parallelism in diabetic nephropathy and diabetic retinopathy.糖尿病肾病和糖尿病视网膜病变中的平行与非平行现象。
Front Endocrinol (Lausanne). 2024 Feb 14;15:1336123. doi: 10.3389/fendo.2024.1336123. eCollection 2024.
6
Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis.阿柏西普治疗糖尿病性黄斑水肿和增生性糖尿病视网膜病变的长期疗效:一项荟萃分析。
Front Endocrinol (Lausanne). 2023 May 16;14:1144422. doi: 10.3389/fendo.2023.1144422. eCollection 2023.
7
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.增生性糖尿病性视网膜病变在糖尿病性视网膜病变患者中发展和进展的预测因素。
Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2.
8
Clinical profile and magnitude of diabetic retinopathy: An electronic medical record-driven big data analytics from an eye care network in India.临床特征与糖尿病视网膜病变的严重程度:来自印度眼科保健网络的电子病历驱动的大数据分析。
Indian J Ophthalmol. 2021 Nov;69(11):3110-3117. doi: 10.4103/ijo.IJO_1490_21.